ING Groep NV Invests $350,000 in Kindred Healthcare, Inc. (NYSE:KND)

ING Groep NV bought a new position in shares of Kindred Healthcare, Inc. (NYSE:KND) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 30,000 shares of the health services provider’s stock, valued at approximately $350,000.

Several other large investors have also modified their holdings of KND. BlackRock Inc. boosted its stake in shares of Kindred Healthcare by 41,968.4% in the first quarter. BlackRock Inc. now owns 10,779,191 shares of the health services provider’s stock worth $90,006,000 after buying an additional 10,753,568 shares during the period. Wellington Management Group LLP boosted its stake in shares of Kindred Healthcare by 40.9% in the first quarter. Wellington Management Group LLP now owns 7,945,247 shares of the health services provider’s stock worth $66,342,000 after buying an additional 2,307,814 shares during the period. Point72 Asset Management L.P. boosted its stake in shares of Kindred Healthcare by 303.1% in the first quarter. Point72 Asset Management L.P. now owns 1,734,899 shares of the health services provider’s stock worth $14,486,000 after buying an additional 1,304,499 shares during the period. Norges Bank acquired a new stake in shares of Kindred Healthcare during the fourth quarter worth approximately $8,342,000. Finally, Bogle Investment Management L P DE acquired a new stake in shares of Kindred Healthcare during the first quarter worth approximately $3,085,000. Institutional investors and hedge funds own 89.79% of the company’s stock.

Shares of Kindred Healthcare, Inc. (NYSE:KND) traded up 1.99% on Friday, reaching $7.70. 3,112,295 shares of the company’s stock traded hands. Kindred Healthcare, Inc. has a 52 week low of $5.65 and a 52 week high of $11.90. The stock’s market capitalization is $670.05 million. The stock’s 50-day moving average price is $9.69 and its 200-day moving average price is $9.21.

Kindred Healthcare (NYSE:KND) last posted its quarterly earnings data on Thursday, August 3rd. The health services provider reported $0.19 EPS for the quarter, beating the Zacks’ consensus estimate of $0.16 by $0.03. Kindred Healthcare had a negative net margin of 16.31% and a positive return on equity of 3.49%. The company had revenue of $1.53 billion during the quarter, compared to the consensus estimate of $1.59 billion. During the same quarter in the prior year, the company posted $0.38 EPS. The company’s quarterly revenue was down 4.6% compared to the same quarter last year. Equities analysts predict that Kindred Healthcare, Inc. will post $0.53 EPS for the current year.

TRADEMARK VIOLATION NOTICE: This news story was originally posted by Community Financial News and is owned by of Community Financial News. If you are viewing this news story on another website, it was illegally copied and republished in violation of US & international trademark & copyright laws. The correct version of this news story can be accessed at https://www.com-unik.info/2017/08/19/ing-groep-nv-acquires-shares-of-30000-kindred-healthcare-inc-nyseknd-updated.html.

A number of equities research analysts have recently commented on KND shares. Zacks Investment Research upgraded shares of Kindred Healthcare from a “hold” rating to a “buy” rating and set a $11.00 target price for the company in a research report on Wednesday, May 3rd. Royal Bank Of Canada reissued a “hold” rating and issued a $10.00 price objective on shares of Kindred Healthcare in a report on Monday, May 15th. Barclays PLC reissued a “buy” rating and issued a $13.00 price objective (up previously from $11.00) on shares of Kindred Healthcare in a report on Sunday, May 7th. BidaskClub lowered shares of Kindred Healthcare from a “buy” rating to a “hold” rating in a report on Wednesday, July 12th. Finally, Deutsche Bank AG dropped their price objective on shares of Kindred Healthcare from $13.00 to $10.00 and set a “buy” rating for the company in a report on Monday, August 7th. Four research analysts have rated the stock with a sell rating, five have issued a hold rating and two have given a buy rating to the company. Kindred Healthcare presently has an average rating of “Hold” and an average target price of $9.94.

Kindred Healthcare Company Profile

Kindred Healthcare, Inc is a healthcare services company. The Company, through its subsidiaries, operates transitional care (TC) hospitals, a home health, hospice and community care business, inpatient rehabilitation hospitals (IRFs), a contract rehabilitation services business, nursing centers and assisted living facilities across the United States.

Institutional Ownership by Quarter for Kindred Healthcare (NYSE:KND)

What are top analysts saying about Kindred Healthcare Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Kindred Healthcare Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit